Sep 12, 2024
ASTRAZENECA CANADA PARTNERS WITH THE LEUKEMIA & LYMPHOMA SOCIETY OF CANADA TO DRIVE CHANGE IN BLOOD CANCER RESEARCH
Sep 10, 2024
SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing
Sep 10, 2024
Pillar Biosciences Partners with AstraZeneca to Help Accelerate Access to Liquid Biopsy Testing
Jun 04, 2024
AbelZeta announces clinical data showing preliminary anti-tumor activity for C-CAR031, an armored autologous GPC3 CAR-T, in patients with advanced hepatocellular carcinoma, at ASCO Annual Meeting 2024
Feb 07, 2024
SOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in Spain
Feb 23, 2021
Lung Cancer Research Foundation Announces New Research Collaboration with AstraZeneca
Feb 16, 2021
AliveCor Announces Collaboration with AstraZeneca to Develop Non-Invasive Potassium Monitoring Solutions
Nov 23, 2020
Ionis announces third investigational antisense medicine to treat nonalcoholic steatohepatitis (NASH) enters development
Sep 17, 2020
Dogma Therapeutics Announces Global Acquisition of Oral PCSK9 Inhibitor Program by AstraZeneca
Sep 14, 2020
Thermo Fisher Scientific Announces Collaborations to Meet Unmet Clinical Needs in Biomarker Discovery and Characterization
Aug 13, 2020
Sosei Heptares Operational Highlights and Consolidated Results for the First Half 2020
Jul 15, 2020
Contribution From AstraZeneca Will Support The American Cancer Society's Mission To Continue Serving Cancer Patients And Caregivers During The COVID-19 Pandemic
Jun 21, 2020
Ascentage Pharma Enters Clinical Collaboration to Evaluate the Combination of Bcl-2 and BTK Inhibitors
Jun 17, 2020
Leukemia Therapeutics Markets, 2015-2025 - Size by Value & Volume, Trends & Developments, Competitive Landscape
Jun 17, 2020
RareiTi Inc.(TM) Names Pharma Industry Veteran and Clinician Alex Evans as CEO
Jun 16, 2020
Cobra Biologics signs supply agreement with AstraZeneca for manufacture of COVID-19 vaccine candidate
Jun 15, 2020
Respiratory Diseases Drugs Market Analysis - Global Outlook and Anlaysis of COVID-19 Implications for the Industry
Jun 11, 2020
Sirnaomics Announces Decision to Spin off RNAimmune to Develop Novel mRNA Therapeutics and Vaccines
Jun 01, 2020
AGC Biologics Acquires Commercial Facility, Expanding Global Service Offerings
May 26, 2020
ArcherDX Announces Strategic Collaboration with AstraZeneca to Develop Personalized Cancer Monitoring (PCM) Assays for Minimal Residual Disease (MRD)